Beejay Feliciano, MD
Vascular Surgery · Spokane, WANPI 1235273632
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,925 of the $4,715 with a category attached, or 62.0%. 31 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 33.7% of the total. That places this record below the midpoint for vascular surgery clinicians in WA, where the typical reported total is $4,221.
Across 86 payments — averaging $54.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$2K
- Medtronic$2K
- Inari Medical, Inc.$176
- Bard Peripheral Vascular, Inc.$145
- Penumbra, Inc.$141
- Bolton Medical Inc$137
- plus $952 from 25 others
What the payments were for
- Speaking & faculty fees$1,18825%
- Travel & lodging$60213%
- Food & beverage$2,92562%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 18 | $1,588 |
| Medtronic(2 entities) | 14 | $1,576 |
| Inari Medical, Inc. | 1 | $176 |
| Bard Peripheral Vascular, Inc. | 8 | $145 |
| Penumbra, Inc. | 2 | $141 |
| Bolton Medical Inc | 1 | $137 |
| Abbott | 2 | $115 |
| Johnson & Johnson | 5 | $102 |
| Solventum Corporation | 3 | $77 |
| Boston Scientific | 3 | $62 |
| Avita Medical Americas, LLC | 2 | $54 |
| Cook Medical LLC | 3 | $52 |
| Cardiovascular Systems Inc. | 3 | $45 |
| E.r. Squibb & Sons, L.L.C. | 3 | $41 |
| Cordis US CORP. | 1 | $40 |
| Shockwave Medical, Inc | 2 | $40 |
| Philips North America LLC | 1 | $34 |
| Terumo Medical Corporation | 1 | $28 |
| Convatec Inc. | 1 | $27 |
| Organogenesis Inc. | 1 | $27 |
| Silk Road Medical, Inc. | 1 | $26 |
| Teleflex LLC | 1 | $22 |
| Chiesi USA, Inc. | 1 | $22 |
| Lemaitre Vascular, Inc. | 1 | $22 |
| Globus Medical | 1 | $21 |
| Braintree Laboratories, Inc. | 1 | $19 |
| Artivion, Inc. | 1 | $16 |
| Amgen | 1 | $16 |
| Intercept Pharmaceuticals, Inc. | 1 | $15 |
| Mimedx Group, Inc. | 1 | $14 |
| Haemonetics Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ClosureFast$1,188
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$799
- FLOWTRIEVER CATHETER, S$176
- CT THROMBECTOMY SYSTEM KIT$176
- GORE EXCLUDER AAA Endoprosthesis$168
- GORE TAG Conformable Thoracic Endoprosthesis$152
- TREO ABDOMINAL STENT-GRAFT SYSTEM$137
- Penumbra System$126
- GORE TAG Thoracic Branch Endoprosthesis$116
- Endurant$108
How this compares
$4,715 in reported general payments places this provider in the 50th percentile of 111 vascular surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 75 | $74,251 |
| ClopidogrelClopidogrel Bisulfate | 52 | $465 |
| Cilostazol | 20 | $423 |
| Oxycodone Hcl | 33 | $82 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $102 | $74,25175 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 111 vascular surgery providers in Washington.
Other vascular surgery in Spokane
- Stephen MurraySpokane$38K
- Adnan RizviSpokane$23K
- Hassan TehraniSpokane$7K
- Joseph DavisSpokane$4K
- Luke ZhanSpokane$4K
- Benjamin StarnesSeatle$666K
- Kathleen GibsonBellevue$593K
- Brian FerrisBellevue$170K
- Sara ZettervallSeattle$126K
- Paul HayesSeattle$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.